MicroRNA-Mediated Inhibition of Amyloid Beta Protein Synthesis in Alzheimer’s Disease: A Research Protocol
Bibliographic record
Abstract
Introduction: Alzheimer’s disease (AD) is a currently incurable neurodegenerative disorder that is defined by the buildup of amyloid beta peptide (Aβ) plaques in the brain. Herein, we aim to investigate two microRNA (miRNA), miR-106b and miR-153, for their ability to inhibit the synthesis of amyloid beta precursor protein. Since miR-106b and miR-153 are also deficient in AD patients, we hypothesize that increasing their concentrations in the brain will reduce plaque development, thereby ameliorating AD symptoms. Methods: Six groups of mice will be reared: a control group of healthy C57BL/6J mice; a control group of diseased B6.Cg-Tg(Thy1-APP)3Somm/J mice; 2 control groups of B6.Cg-Tg(Thy1-APP)3Somm/J mice, one treated an empty mini-osmotic pump, the other treated with functionless miRNA; and two treatment groups of B6.Cg-Tg(Thy1-APP)3Somm/J mice treated with miR-106b and miR-153 each. Then, a Morris water maze test and ELISA analysis will be conducted on each group to determine the effectiveness of the miRNA treatment at reducing Aβ plaque and AD symptoms. Discussion: As a proof of concept study, this experiment may determine whether miRNAs can alleviate AD symptoms and plaque development. There may be limitations regarding the applicability of murine models, as well as the implementation of induced AD in the genetically modified mice. The results of each experimental group will be compared using an ANOVA, and qualitatively for improvement of cognitive functioning. Conclusion: This experiment suggests an approach to counter the deleterious effects of AD. Future studies may investigate less invasive methods of administering miRNA treatments.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.003 | 0.001 |
| Meta-epidemiology (narrow) | 0.002 | 0.001 |
| Meta-epidemiology (broad) | 0.002 | 0.002 |
| Bibliometrics | 0.001 | 0.001 |
| Science and technology studies | 0.002 | 0.001 |
| Scholarly communication | 0.001 | 0.001 |
| Open science | 0.002 | 0.001 |
| Research integrity | 0.002 | 0.002 |
| Insufficient payload (model declined to judge) | 0.024 | 0.010 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".